Cabozantinib in Patients With Advanced Hepatocellular Carcinoma With Child Pugh Class B Cirrhosis After First-Line Therapy

NCT04497038 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

TERMINATED

Status

3

Enrollment

OTHER

Sponsor class

Stopped loss of funding

Conditions

Advanced Adult Hepatocellular Carcinoma

Interventions

DRUG: Cabozantinib

Sponsor

University of Michigan Rogel Cancer Center

Collaborators

[object Object]